Synonym |
N/A |
Species |
N/A |
Protein Accession |
N/A |
Purity |
N/A |
Endotoxin Level |
N/A |
Biological Activity |
N/A |
Expression System |
N/A |
Fusion Tag |
N/A |
Predicted Molecular Mass |
N/A |
Formulation |
N/A |
Reconstitution |
N/A |
Storage & Stability |
N/A |
FAQ
What is Ac-Lys-(D-Ala)2-OH and how is it typically used in research
applications?
Ac-Lys-(D-Ala)2-OH, also known as N-acetyl-L-lysyl-D-alanyl-D-alanine, is a custom
peptide frequently utilized in biochemical and pharmaceutical research. It is an engineered molecule
where the lysine (Lys) is acetylated, and the peptide sequence is further enhanced with two units of
D-Alanine. This configuration allows for unique interactions within biological systems, often serving as
a reliable model for studying peptide behaviors and interactions. The acetylation of the lysine residue
can influence the peptide's charge, solubility, and interaction with proteins and cells, making it a
versatile tool for researchers.
In research applications, Ac-Lys-(D-Ala)2-OH can be employed as a
substrate for enzymatic reactions, a structural mimic to study protein-peptide interactions, or even in
drug development for targeting specific physiological pathways. Its particular sequence is relevant in
understanding antimicrobial resistance, as it mimics components of bacterial cell walls, enabling the
study of β-lactamases or other peptidase activities. Researchers may utilize it to dissect the
intricacies of resistance mechanisms or to screen for potential inhibitors that can prevent these
enzymes from functioning, which is particularly crucial in developing new antibiotics.
In drug
development, its customized sequence allows scientists to establish SAR (structure-activity
relationship) models enabling the optimization of peptide-based therapeutics. Furthermore, modified
peptides like Ac-Lys-(D-Ala)2-OH can serve as scaffolds for the introduction of other functional groups,
thus expanding their utility in diverse experimental conditions. When scientists need a stable,
reliable, and functionalized peptide that mimics biological activities or augments natural sequences,
Ac-Lys-(D-Ala)2-OH emerges as an invaluable resource. Its synthesis and application in bio-molecular
research continue to aid in the design and testing of new drugs and biochemical assays, driving forward
our understanding of complex biological processes and therapeutic discovery.
What are the
advantages of using Ac-Lys-(D-Ala)2-OH in scientific studies over other peptides?
The strategic
use of Ac-Lys-(D-Ala)2-OH in scientific studies offers a number of distinct advantages over other
peptides. To begin with, its structural uniqueness provides enhanced stability, allowing it to resist
unwanted enzymatic degradation, which is a common challenge with naturally occurring peptides. Because
of the inclusion of D-Alanine residues, this peptide is less prone to rapid breakdown by peptidases that
typically target L-form amino acids. As a result, it remains intact and functional longer in
experimental setups, granting researchers better control and more reliable data over extended periods of
time.
Another significant advantage is the chemical flexibility that Ac-Lys-(D-Ala)2-OH presents.
The presence of an acetylated lysine moiety allows for a reduction in the positive charge at the
peptide's N-terminus, increasing its solubility and reducing potential non-specific interactions with
negatively charged cellular components. This leads to a higher degree of selectivity and accuracy in
studies aimed at deciphering specific protein-peptide interactions or cellular uptake mechanisms. The
acetylation also adds cosmetic modularity, thereby allowing researchers to further modify the peptide if
required, tailoring its characteristics to the needs of the experiment.
Furthermore,
Ac-Lys-(D-Ala)2-OH can serve as an effective proxy for understanding mechanisms of resistance in
bacteria, particularly concerning β-lactam antibiotics. Its similarity to components of bacterial cell
wall precursors enables researchers to study substrate-enzyme interaction, especially with enzymes that
confer resistance by breaking down these antibiotics. Through such studies, valuable insights into how
bacterial resistance develops and persists can be gleaned, informing the design of novel interventions
or therapeutic agents designed to counteract resistant strains.
The combination of durability,
selective interaction, and practical mimicry makes Ac-Lys-(D-Ala)2-OH a powerful tool for in-depth
research, bridging the gap between empirical biology and medicinal chemistry. Researchers benefit from
this compound's enhanced stability and specificity, which contributes to reproducible and meaningful
outcomes in experimental research settings. For applications that demand high accuracy, reliability, and
adaptability, Ac-Lys-(D-Ala)2-OH often stands out as the peptide of choice.
How does the presence
of D-amino acids in Ac-Lys-(D-Ala)2-OH affect its biological activity?
The incorporation of
D-amino acids in Ac-Lys-(D-Ala)2-OH significantly influences the peptide's biological activity, a
cornerstone aspect for its utility in scientific research. Natural proteins and peptides predominantly
consist of L-amino acids; thus, the use of D-amino acids such as D-Alanine in Ac-Lys-(D-Ala)2-OH, which
constitutes its structure, bestows upon it unique characteristics not typically observed in endogenous
peptides. This variation leads to an increase in resistance to proteolytic enzymes, as most proteases
recognize and cleave L-amino acid sequences. Consequently, the peptide's half-life is extended in
biological systems, allowing researchers prolonged observation periods and reduced degradation during
experimentation.
The presence of D-amino acids also impacts the peptide's conformational
attributes, affecting how it interacts with other biomolecules. The distinctive stereochemistry of
D-amino acids modifies the tertiary structure that the peptide can adopt, possibly altering receptor
binding interactions and specificity. This can either enhance or reduce the affinity of the peptide for
its target, depending on the unique requirements of the experimental design. In pharmaceutical research,
this aspect is particularly beneficial, as it allows for the fine-tuning of peptide-receptor
interactions, often a pivotal step in drug development and design.
Moreover, the D-amino acids
may impart resistance or modify the interaction profile of the peptide with bacterial enzymes and
proteins. For example, in the study of antibiotics and bacterial cell wall synthesis, a peptide like
Ac-Lys-(D-Ala)2-OH can serve as a mimic to understand how bacterial proteins bind and interact with
their natural substrates. This can be instrumental in identifying new targets or designing inhibitors
that either incapacitate harmful bacteria or block unwanted biochemical pathways.
By offering
structural stability and altered interaction dynamics, the inclusion of D-amino acids ensures that
Ac-Lys-(D-Ala)2-OH remains robust in various experimental conditions. Researchers can explore
biochemical pathways and protein interactions with greater precision, utilize the peptide in assays
where traditional L-peptide offerings may fall short, and leverage its unique properties to drive
forward innovative discoveries in drug development and disease understanding. The strategic inclusion of
D-alanine thus not only provides functional benefits but also broadens the horizon for
Ac-Lys-(D-Ala)2-OH's application across various domains of scientific inquiry.
Can
Ac-Lys-(D-Ala)2-OH be used for drug development? If so, how?
Ac-Lys-(D-Ala)2-OH holds significant
promise as a scaffold for drug development due to its structural and biochemical properties. The design
of this peptide allows it not only to function as a robust model for studying biological activities but
also to serve as a potential starting point for the synthesis of novel therapeutic agents. One of the
compelling aspects of using Ac-Lys-(D-Ala)2-OH in drug development is its stable yet modifiable
structure. The acetylated lysine endows the peptide with an increased solubility and reduced charge,
facilitating easier modification and conjugation to other molecules. Meanwhile, the presence of D-amino
acids within its sequence enhances its durability, offering resistance against enzymatic degradation
which is often pivotal for therapeutic peptides that require a longer half-life in the systemic
circulation.
In drug development, peptides like Ac-Lys-(D-Ala)2-OH can be optimized for specific
target interactions based on their conformation and binding affinity. The unique stereochemistry
provided by the D-alanine residues allows for a potentially unique binding profile that can be utilized
to interact with targets that are not easily reached by either natural peptides or small molecules. This
attribute can be leveraged to design inhibitors or modulators that target specific biological pathways
implicated in diseases, expanding the possibilities for innovative therapeutic interventions.
Furthermore, Ac-Lys-(D-Ala)2-OH can serve as a lead compound in the development of antimicrobial agents,
especially given its similarity to structural motifs found in bacterial cell wall components. This can
provide insights into the development of new antibiotics that evade typical mechanisms of resistance,
which is a pressing need given the current global challenge of antibiotic resistance.
Moreover,
Ac-Lys-(D-Ala)2-OH could be employed in tandem with drug delivery systems, such as nanoparticles or
biodegradable polymers, where its modified peptide structure might improve delivery efficacy or system
stability. In such instances, the peptide could be used to target specific cells or tissues, paving the
way for personalized and site-specific therapeutic strategies.
In summary, Ac-Lys-(D-Ala)2-OH
possesses substantive qualities amenable to drug development, whether through direct bioactivity,
interaction studies, or as a vector component in advanced delivery systems. Its unique construction
combines stability and specificity, offering a versatile platform for pharmaceutical innovations.
Researchers interested in peptide-based therapeutics will find Ac-Lys-(D-Ala)2-OH to be an engaging
candidate with a wealth of opportunities for exploration and utilization across different therapeutic
landscapes.
What challenges might researchers face when working with Ac-Lys-(D-Ala)2-OH in
laboratory settings?
While Ac-Lys-(D-Ala)2-OH offers a wealth of potential applications in
research and development, working with this peptide in laboratory settings can present several
challenges that need careful consideration. One primary challenge is synthesis and purity. Given the
sophisticated nature of peptides and their susceptibility to alterations during synthesis, ensuring the
purity and consistency of Ac-Lys-(D-Ala)2-OH remains a meticulous task. Peptide synthesis often requires
precise conditions, reagents, and methodologies, such as solid-phase peptide synthesis (SPPS), which
demands high precision and expertise. Consequently, researchers must meticulously verify the integrity
and purity of the peptide, often necessitating advanced analytical techniques such as HPLC or mass
spectrometry, which might not always be readily available in all laboratories.
Another potential
challenge is solubility and handling. Even though Ac-Lys-(D-Ala)2-OH is engineered to enhance
solubility, variations in solvent choice can impact its solubility and stability. Researchers must
carefully select appropriate solvents and buffers to maintain peptide stability and prevent aggregation,
particularly when conducting prolonged assays or experiments. Additionally, the peptide’s reactivity
with other reagents must be considered to prevent side reactions that may alter experimental outcomes or
interpretations.
Scalability can also pose a hurdle when researchers seek to translate
small-scale assays into larger ones. Due to the complex nature of peptide synthesis and batch
variability, scaling up production while retaining peptide functionality and purity can be demanding.
Laboratories might need to invest in technology or specialized personnel capable of handling such
complex synthesis and purification processes at a larger scale.
Furthermore, the unique
stereochemistry of Ac-Lys-(D-Ala)2-OH, while advantageous for specific applications, necessitates
careful controls during experimentation to ensure accurate results. The presence of D-amino acids might
alter expected interaction pathways, which means any deviations from predicted outcomes need thorough
investigation to differentiate between methodological error or novel mechanistic insight.
Lastly,
storage and stability pose a challenge as they require optimized conditions for maintaining peptide
integrity over prolonged periods. Temperature fluctuations, humidity, and exposure to air could degrade
the peptide, so careful storage conditions must be observed. Investing in specialized storage may also
lead to increased costs.
In addressing these challenges, researchers must leverage precise
methodologies, often requiring significant investment in both technology and training, to ensure the
reliable use of Ac-Lys-(D-Ala)2-OH in their respective applications. Mitigating these challenges
efficiently can enable scientists to harness the full potential of this peptide in advancing research
endeavors.